{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T02:50:18Z","timestamp":1772160618990,"version":"3.50.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82260546"],"award-info":[{"award-number":["82260546"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20224BAB206062"],"award-info":[{"award-number":["20224BAB206062"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-77401-x","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T10:03:21Z","timestamp":1730109801000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Druggable targets for Parkinson\u2019s disease: transcriptomics based Mendelian randomization study"],"prefix":"10.1038","volume":"14","author":[{"given":"Qiong","family":"Lyu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuhuai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongrong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,28]]},"reference":[{"key":"77401_CR1","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.mcna.2018.10.014","volume":"103","author":"SG Reich","year":"2019","unstructured":"Reich, S. G. & Savitt, J. M. Parkinson\u2019s disease. Med. Clin. North Am. 103, 337\u2013350 (2019).","journal-title":"Med. Clin. North Am."},{"key":"77401_CR2","doi-asserted-by":"crossref","unstructured":"Jankovic, J. & Tan, E. K. Parkinson\u2019s disease: etiopathogenesis and treatment. J. Neurol. Neurosurg. Psychiatry 91 (2020).","DOI":"10.1136\/jnnp-2019-322338"},{"key":"77401_CR3","doi-asserted-by":"crossref","unstructured":"Riboldi, G. M., Frattini, E., Monfrini, E., Frucht, S. J. & Di Fonzo, A. A practical approach to early-onset parkinsonism. J. Parkinson\u2019s Dis. 12 (2022).","DOI":"10.3233\/JPD-212815"},{"key":"77401_CR4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/mds.25273","volume":"28","author":"LV Kalia","year":"2013","unstructured":"Kalia, L. V., Brotchie, J. M. & Fox, S. H. Novel nondopaminergic targets for motor features of Parkinson\u2019s disease: review of recent trials. Mov. Disord. 28, 131\u2013144 (2013).","journal-title":"Mov. Disord."},{"key":"77401_CR5","doi-asserted-by":"crossref","unstructured":"Haddad, F., Sawalha, M., Khawaja, Y., Najjar, A. & Karaman, R. Dopamine and levodopa prodrugs for the treatment of Parkinson\u2019s disease. Molecules (Basel, Switzerland) 23 (2017).","DOI":"10.3390\/molecules23010040"},{"key":"77401_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.gaitpost.2023.01.022","volume":"101","author":"C Herbers","year":"2023","unstructured":"Herbers, C. et al. Dopamine replacement therapy normalizes reactive step length to postural perturbations in Parkinson\u2019s disease. Gait Posture 101, 95\u2013100 (2023).","journal-title":"Gait Posture"},{"key":"77401_CR7","doi-asserted-by":"crossref","unstructured":"You, H. Molecular basis of dopamine replacement therapy and its side effects in Parkinson\u2019s disease. Cell Tissue Res. 373 (2018).","DOI":"10.1007\/s00441-018-2813-2"},{"key":"77401_CR8","doi-asserted-by":"crossref","unstructured":"Day, J. O. & Mullin, S. The genetics of Parkinson\u2019s disease and implications for clinical practice. Genes 12 (2021).","DOI":"10.3390\/genes12071006"},{"key":"77401_CR9","doi-asserted-by":"crossref","unstructured":"Pajares, M., I. Rojo, A., Manda, G., Bosc\u00e1, L. & Cuadrado, A. Inflammation in Parkinson\u2019s disease: mechanisms and therapeutic implications. Cells 9 (2020).","DOI":"10.3390\/cells9071687"},{"key":"77401_CR10","doi-asserted-by":"crossref","unstructured":"Polissidis, A., Petropoulou-Vathi, L., Nakos-Bimpos, M. & Rideout, H. The future of targeted gene-based treatment strategies and biomarkers in Parkinson\u2019s disease. Biomolecules 10 (2020).","DOI":"10.3390\/biom10060912"},{"key":"77401_CR11","doi-asserted-by":"crossref","unstructured":"Park, J., Davis, R. & Sue, C. Mitochondrial dysfunction in Parkinson\u2019s disease: new mechanistic insights and therapeutic perspectives. Curr. Neurol. Neurosci. Rep. 18 (2018).","DOI":"10.1007\/s11910-018-0829-3"},{"key":"77401_CR12","doi-asserted-by":"crossref","unstructured":"Zhang, P. F. & Gao, F. Neuroinflammation in Parkinson\u2019s disease: a meta-analysis of PET imaging studies. J. Neurol. 269 (2022).","DOI":"10.1007\/s00415-021-10877-z"},{"key":"77401_CR13","doi-asserted-by":"crossref","unstructured":"Li T & Le W. Biomarkers for Parkinson\u2019s disease: how good are they? Neurosci. Bull. 36 (2020).","DOI":"10.1007\/s12264-019-00433-1"},{"key":"77401_CR14","doi-asserted-by":"crossref","unstructured":"King, E., Davis, J. & Degner, J. Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval. PLoS Genet. 15 (2019).","DOI":"10.1101\/513945"},{"key":"77401_CR15","doi-asserted-by":"crossref","unstructured":"Nelson, M. R. et al. The support of human genetic evidence for approved drug indications. Nat. Genet. 47 (2015).","DOI":"10.1038\/ng.3314"},{"key":"77401_CR16","doi-asserted-by":"crossref","unstructured":"Finan, C. et al. The druggable genome and support for target identification and validation in drug development. Sci. Transl. Med. 9 (2017).","DOI":"10.1126\/scitranslmed.aag1166"},{"key":"77401_CR17","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.tig.2018.04.004","volume":"34","author":"M Floris","year":"2018","unstructured":"Floris, M., Olla, S., Schlessinger, D. & Cucca, F. Genetic-driven druggable target identification and validation. Trends Genet. 34, 558\u2013570 (2018).","journal-title":"Trends Genet."},{"key":"77401_CR18","doi-asserted-by":"publisher","first-page":"7342","DOI":"10.1038\/s41467-021-26280-1","volume":"12","author":"CS Storm","year":"2021","unstructured":"Storm, C. S. et al. Finding genetically-supported drug targets for Parkinson\u2019s disease using Mendelian randomization of the druggable genome. Nat. Commun. 12, 7342 (2021).","journal-title":"Nat. Commun."},{"key":"77401_CR19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1136\/ebmental-2019-300085","volume":"22","author":"P Pagoni","year":"2019","unstructured":"Pagoni, P., Dimou, N. L., Murphy, N. & Stergiakouli, E. Using Mendelian randomisation to assess causality in observational studies. Evid. Based Ment. Health 22, 67\u201371 (2019).","journal-title":"Evid. Based Ment. Health"},{"key":"77401_CR20","doi-asserted-by":"crossref","unstructured":"Sekula, P., Del Greco M, F., Pattaro, C. & K\u00f6ttgen, A. Mendelian randomization as an approach to assess causality using observational data. J. Am. Soc. Nephrol. 27, 3253\u20133265 (2016).","DOI":"10.1681\/ASN.2016010098"},{"key":"77401_CR21","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/S0140-6736(12)60110-X","volume":"379","author":"DI Swerdlow","year":"2012","unstructured":"Swerdlow, D. I. et al. The interleukin-6 receptor as a target for prevention of coronary heart disease: a Mendelian randomisation analysis. Lancet 379, 1214\u20131224 (2012).","journal-title":"Lancet"},{"key":"77401_CR22","unstructured":"Gaziano, L. et al. Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19. Nat. Med. 27 (2021)."},{"key":"77401_CR23","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S1474-4422(19)30287-X","volume":"19","author":"C Blauwendraat","year":"2020","unstructured":"Blauwendraat, C., Nalls, M. A. & Singleton, A. B. The genetic architecture of Parkinson\u2019s disease. Lancet Neurol. 19, 170\u2013178 (2020).","journal-title":"Lancet Neurol."},{"key":"77401_CR24","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1093\/brain\/awae111","volume":"147","author":"C Wu","year":"2024","unstructured":"Wu, C. et al. Identifying novel risk genes in intracranial aneurysm by integrating human proteomes and genetics. Brain 147, 2817\u20132825 (2024).","journal-title":"Brain"},{"key":"77401_CR25","doi-asserted-by":"publisher","first-page":"6430","DOI":"10.1038\/s41467-024-50718-x","volume":"15","author":"A Doostparast Torshizi","year":"2024","unstructured":"Doostparast Torshizi, A. et al. Proteogenomic network analysis reveals dysregulated mechanisms and potential mediators in Parkinson\u2019s disease. Nat. Commun. 15, 6430 (2024).","journal-title":"Nat. Commun."},{"key":"77401_CR26","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41531-019-0080-x","volume":"5","author":"KJ Billingsley","year":"2019","unstructured":"Billingsley, K. J. et al. Mitochondria function associated genes contribute to Parkinson\u2019s Disease risk and later age at onset. NPJ Parkinsons Dis. 5, 8 (2019).","journal-title":"NPJ Parkinsons Dis."},{"key":"77401_CR27","doi-asserted-by":"crossref","unstructured":"Freshour, S. L. et al. Integration of the Drug-Gene Interaction Database (DGIdb 4.0) with open crowdsource efforts. Nucleic Acids Res. 49, D1144\u2013D1151 (2021).","DOI":"10.1093\/nar\/gkaa1084"},{"key":"77401_CR28","doi-asserted-by":"crossref","unstructured":"Mohammad, N., Nazli, R., Zafar, H. & Fatima, S. Effects of lipid based Multiple Micronutrients Supplement on the birth outcome of underweight pre-eclamptic women: A randomized clinical trial. Pak. J. Med. Sci. 38,(2022).","DOI":"10.12669\/pjms.38.1.4396"},{"key":"77401_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i03","volume":"36","author":"W Viechtbauer","year":"2010","unstructured":"Viechtbauer, W. Conducting meta-analyses in R with the metafor Package. J. Stat. Softw. 36, 1\u201348 (2010).","journal-title":"J. Stat. Softw."},{"key":"77401_CR30","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B (Methodol.) 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc. Ser. B (Methodol.)"},{"key":"77401_CR31","doi-asserted-by":"crossref","unstructured":"Wu, T. et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation (Camb) 2, 100141 (2021).","DOI":"10.1016\/j.xinn.2021.100141"},{"key":"77401_CR32","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. & Ishiguro-Watanabe, M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51, D587\u2013D592 (2023).","journal-title":"Nucleic Acids Res."},{"key":"77401_CR33","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"77401_CR34","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417\u2013425 (2015).","journal-title":"Cell Syst."},{"key":"77401_CR35","unstructured":"Wang, D. et al. Comprehensive functional genomic resource and integrative model for the human brain. Science 362, eaat8464 (2018)."},{"key":"77401_CR36","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","volume":"53","author":"U V\u00f5sa","year":"2021","unstructured":"V\u00f5sa, U. et al. Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat. Genet. 53, 1300\u20131310 (2021).","journal-title":"Nat. Genet."},{"key":"77401_CR37","doi-asserted-by":"crossref","unstructured":"GTEx Consortium. The Genotype-Tissue Expression (GTEx) project. Nat. Genet. 45, 580\u2013585 (2013).","DOI":"10.1038\/ng.2653"},{"key":"77401_CR38","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","volume":"18","author":"MA Nalls","year":"2019","unstructured":"Nalls, M. A. et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 18, 1091\u20131102 (2019).","journal-title":"Lancet Neurol."},{"key":"77401_CR39","doi-asserted-by":"publisher","unstructured":"Elsworth, B. et al. The MRC IEU OpenGWAS data infrastructure. bioRxiv. https:\/\/doi.org\/10.1101\/2020.08.10.244293 (2020).","DOI":"10.1101\/2020.08.10.244293"},{"key":"77401_CR40","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.34408","volume":"7","author":"G Hemani","year":"2018","unstructured":"Hemani, G. et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife 7, e34408 (2018).","journal-title":"Elife"},{"key":"77401_CR41","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/ng.3538","volume":"48","author":"Z Zhu","year":"2016","unstructured":"Zhu, Z. et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat. Genet. 48, 481\u2013487 (2016).","journal-title":"Nat. Genet."},{"key":"77401_CR42","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/s41467-018-03371-0","volume":"9","author":"Y Wu","year":"2018","unstructured":"Wu, Y. et al. Integrative analysis of omics summary data reveals putative mechanisms underlying complex traits. Nat. Commun. 9, 918 (2018).","journal-title":"Nat. Commun."},{"key":"77401_CR43","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1038\/s41588-018-0184-y","volume":"50","author":"W Zhou","year":"2018","unstructured":"Zhou, W. et al. Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies. Nat. Genet. 50, 1335\u20131341 (2018).","journal-title":"Nat. Genet."},{"key":"77401_CR44","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41531-022-00321-y","volume":"8","author":"M Beckers","year":"2022","unstructured":"Beckers, M., Bloem, B. R. & Verbeek, M. M. Mechanisms of peripheral levodopa resistance in Parkinson\u2019s disease. NPJ Parkinsons Dis. 8, 56 (2022).","journal-title":"NPJ Parkinsons Dis."},{"key":"77401_CR45","doi-asserted-by":"publisher","first-page":"13370","DOI":"10.3390\/ijms241713370","volume":"24","author":"S Mohammed","year":"2023","unstructured":"Mohammed, S., Russo, I. & Ramazzina, I. Uncovering the role of natural and synthetic small molecules in counteracting the burden of \u03b1-synuclein aggregates and related toxicity in different models of Parkinson\u2019s disease. Int. J. Mol. Sci. 24, 13370 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"77401_CR46","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/s41467-021-21063-0","volume":"12","author":"MM Biebl","year":"2021","unstructured":"Biebl, M. M. et al. Structural elements in the flexible tail of the co-chaperone p23 coordinate client binding and progression of the Hsp90 chaperone cycle. Nat. Commun. 12, 828 (2021).","journal-title":"Nat. Commun."},{"key":"77401_CR47","doi-asserted-by":"crossref","unstructured":"Brembati, V., Faustini, G., Longhena, F., Outeiro, T. & Bellucci, A. Changes in \u03b1-synuclein posttranslational modifications in an AAV-based mouse model of Parkinson\u2019s disease. Int. J. Mol. Sci. 24 (2023).","DOI":"10.3390\/ijms241713435"},{"key":"77401_CR48","doi-asserted-by":"crossref","unstructured":"Desai Bradaric, B., Patel, A., Schneider, J., Carvey, P. & Hendey, B. Evidence for angiogenesis in Parkinson\u2019s disease, incidental Lewy body disease, and progressive supranuclear palsy. J. Neural Transm. (Vienna, Austria: 1996) 119 (2012).","DOI":"10.1007\/s00702-011-0684-8"},{"key":"77401_CR49","doi-asserted-by":"crossref","unstructured":"Gundersen, V. Parkinson\u2019s disease: can targeting inflammation be an effective neuroprotective strategy? Front. Neurosci. 14 (2021).","DOI":"10.3389\/fnins.2020.580311"},{"key":"77401_CR50","doi-asserted-by":"crossref","unstructured":"Wu, L., Xu, Y., Zhao, H. & Li, Y. RNase T2 in inflammation and cancer: immunological and biological views. Front. Immunol. 11 (2020).","DOI":"10.3389\/fimmu.2020.01554"},{"key":"77401_CR51","doi-asserted-by":"crossref","unstructured":"Greulich, W. et al. TLR8 is a sensor of RNase T2 degradation products. Cell 179 (2019).","DOI":"10.1016\/j.cell.2019.11.001"},{"key":"77401_CR52","doi-asserted-by":"crossref","unstructured":"Ostendorf, T. et al. Immune sensing of synthetic, bacterial, and protozoan RNA by toll-like receptor 8 requires coordinated processing by RNase T2 and RNase 2. Immunity 52 (2020).","DOI":"10.1016\/j.immuni.2020.03.009"},{"key":"77401_CR53","doi-asserted-by":"crossref","unstructured":"Burnstock, G. & Kennedy, C. P2X receptors in health and disease. Adv. Pharmacol. (San Diego, Calif.) 61 (2011).","DOI":"10.1016\/B978-0-12-385526-8.00011-4"},{"key":"77401_CR54","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s11302-016-9546-z","volume":"13","author":"MW Metzger","year":"2017","unstructured":"Metzger, M. W. et al. Genetically dissecting P2rx7 expression within the central nervous system using conditional humanized mice. Purinergic Signal. 13, 153\u2013170 (2017).","journal-title":"Purinergic Signal."},{"key":"77401_CR55","doi-asserted-by":"crossref","unstructured":"He, Y., Taylor, N., Fourgeaud, L. & Bhattacharya, A. The role of microglial P2X7: modulation of cell death and cytokine release. J. Neuroinflamm. 14 (2017).","DOI":"10.1186\/s12974-017-0904-8"},{"key":"77401_CR56","doi-asserted-by":"crossref","unstructured":"Liu, T. W., Chen, C. M. & Chang, K. H. Biomarker of neuroinflammation in Parkinson\u2019s disease. Int. J. Mol. Sci. 23 (2022).","DOI":"10.3390\/ijms23084148"},{"key":"77401_CR57","doi-asserted-by":"crossref","unstructured":"Marcellino, D. et al. On the role of P2X(7) receptors in dopamine nerve cell degeneration in a rat model of Parkinson\u2019s disease: studies with the P2X(7) receptor antagonist A-438079. J. Neural Transm. (Vienna, Austria: 1996) 117 (2010).","DOI":"10.1007\/s00702-010-0400-0"},{"key":"77401_CR58","doi-asserted-by":"crossref","unstructured":"Yu, Y. et al. Cellular localization of P2X7 receptor mRNA in the rat brain. Brain Res. 1194 (2008).","DOI":"10.1016\/j.brainres.2007.11.064"},{"key":"77401_CR59","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12964-018-0293-3","volume":"16","author":"P Sekar","year":"2018","unstructured":"Sekar, P., Huang, D. Y., Hsieh, S. L., Chang, S. F. & Lin, W. W. AMPK-dependent and independent actions of P2X7 in regulation of mitochondrial and lysosomal functions in microglia. Cell Commun. Signal. 16, 83 (2018).","journal-title":"Cell Commun. Signal."},{"key":"77401_CR60","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3858\/emm.2011.43.1.001","volume":"43","author":"HG Lee","year":"2011","unstructured":"Lee, H. G., Won, S. M., Gwag, B. J. & Lee, Y. B. Microglial P2X\u2087 receptor expression is accompanied by neuronal damage in the cerebral cortex of the APPswe\/PS1dE9 mouse model of Alzheimer\u2019s disease. Exp. Mol. Med. 43, 7\u201314 (2011).","journal-title":"Exp. Mol. Med."},{"key":"77401_CR61","doi-asserted-by":"crossref","unstructured":"Sarti, A. C. et al. Mitochondrial P2X7 receptor localization modulates energy metabolism enhancing physical performance. Function (Oxf) 2, zqab005 (2021).","DOI":"10.1093\/function\/zqab025"},{"key":"77401_CR62","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1177\/1535370220967325","volume":"246","author":"L Kurvits","year":"2021","unstructured":"Kurvits, L. et al. Transcriptomic profiles in Parkinson\u2019s disease. Exp. Biol. Med. (Maywood) 246, 584\u2013595 (2021).","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"77401_CR63","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12883-016-0784-z","volume":"17","author":"A Planken","year":"2017","unstructured":"Planken, A. et al. Looking beyond the brain to improve the pathogenic understanding of Parkinson\u2019s disease: implications of whole transcriptome profiling of Patients\u2019 skin. BMC Neurol. 17, 6 (2017).","journal-title":"BMC Neurol."},{"key":"77401_CR64","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1177\/15353702221081027","volume":"247","author":"S Koks","year":"2022","unstructured":"Koks, S., Pfaff, A. L., Bubb, V. J. & Quinn, J. P. Longitudinal intronic RNA-Seq analysis of Parkinson\u2019s disease patients reveals disease-specific nascent transcription. Exp. Biol. Med. (Maywood) 247, 945\u2013957 (2022).","journal-title":"Exp. Biol. Med. (Maywood)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77401-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77401-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77401-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T14:05:53Z","timestamp":1730383553000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77401-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,28]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["77401"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-77401-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,28]]},"assertion":[{"value":"19 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests. The illustration was created using the Biorender software.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Because this work was based on publicly available summary-level GWAS data, it does not require an ethical review or informed permission.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"25763"}}